Asked by: Anneliese Midgley (Labour - Knowsley)
Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, what proportion of research funding is allocated to epilepsy research; and if she will make an assessment of the adequacy of this proportion.
Answered by Kanishka Narayan - Parliamentary Under Secretary of State (Department for Science, Innovation and Technology)
The Medical Research Council (MRC), which is part of UK Research and Innovation (UKRI), has committed a total of over £25.5 million since 2018/19 on epilepsy research, including over £9.5 million in 2024/25. This research spans discovery science and fundamental understanding of the disease, through to new approaches for diagnosis and intervention. MRC also supports epilepsy research within its portfolio of larger investments. For example, this includes a new MRC Centre of Research Excellence (CoRE) in Restorative Neural Dynamics which aims to develop brain stimulation devices to treat a range of conditions including childhood epilepsy, and the UK data platform for Traumatic Brain Injury research (TBI-REPORTER) which includes post-traumatic epilepsy as one of the areas of focus.
The Department of Health and Social Care also funds research through the National Institute for Health and Care Research (NIHR). The NIHR has funded a range of ongoing epilepsy research and has awarded £12.8 million to studies in the last five financial years. The NIHR continues to welcome funding applications for research into any aspect of human health and care, including alternative treatments for epilepsy.
Asked by: Anneliese Midgley (Labour - Knowsley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of his Department's funding for epilepsy research.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department funds research into epilepsy via the National Institute for Health and Care Research (NIHR). Between 2020/21 and 2024/25, the NIHR invested £12.8 million in direct research funding on epilepsy. This investment in epilepsy research allows us to continue developing our understanding of the condition and make a real difference to people living with epilepsy, as demonstrated by the examples of impact outlined below.
In 2022, the NIHR-hosted James Lind Alliance (JLA) carried out a UK Epilepsy Priority Setting Partnership (PSP) with epilepsy patients, carers, and service providers to identify the most pressing research priorities for ongoing epilepsy research investment. Many NIHR-funded research projects align to and address the priorities set out by the JLA PSP, boosting epilepsy research. These include:
Other examples of NIHR-funded epilepsy research and impact include:
The NIHR also works closely with other Government funders, including UK Research and Innovation, which is funded by the Department for Science, Innovation and Technology and includes the Medical Research Council, to fund research into epilepsy to improve treatments and prevent poor health outcomes for patients.
The NIHR welcomes funding applications for research into any aspect of human health and care, including epilepsy. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. Welcoming applications on epilepsy to all NIHR programmes enables maximum flexibility both in terms of amount of research funding a particular area can be awarded, and the type of research which can be funded.
Asked by: Anneliese Midgley (Labour - Knowsley)
Question to the Ministry of Housing, Communities and Local Government:
To ask the Secretary of State for Housing, Communities and Local Government, what mechanisms his Department plans to use to monitor the effectiveness of the multi-year Settlement in reducing disparities in funding between more and less deprived local authorities.
Answered by Alison McGovern - Minister of State (Housing, Communities and Local Government)
The government is making good on long overdue promises to fundamentally update the way we fund local authorities. We are realigning funding with need by introducing a fairer and evidence-based funding assessment, which will target a greater proportion of central government grant funding towards the most deprived places which need it the most. By 2028-29, we expect that the 10% most deprived authorities in England will see a significant increase in Core Spending Power per head compared to the least deprived.
The new assessment will be based on the most up-to-date data available. Going forwards, we will update the data at the beginning of each multi-year Settlement to balance dynamism with providing certainty and stability over the Settlement period.
Asked by: Anneliese Midgley (Labour - Knowsley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the cost of epilepsy to (a) the NHS and (b) the wider economy; and how this estimate informs decisions on funding for epilepsy research.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
While the Government has not made a formal estimate of the cost of epilepsy to the National Health Service and the wider economy, we are aware of a report published by Economist Impact in February 2024, titled, The value of action: mitigating the impact of neurological disorders in the United Kingdom, which estimated that idiopathic epilepsy cost the economy £1.7 billion or 0.07% of gross domestic product in 2019. This report is available at the following link:
The Department funds research into epilepsy via the National Institute for Health and Care Research (NIHR). Between 2020/21 and 2024/25, the NIHR invested £12.8 million in direct research funding on epilepsy.
The NIHR welcomes funding applications for research into any aspect of human health and care, including epilepsy. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality. Welcoming applications on epilepsy to all NIHR programmes enables maximum flexibility both in terms of the amount of research funding a particular area can be awarded, and the type of research which can be funded.
Asked by: Anneliese Midgley (Labour - Knowsley)
Question to the Department for Transport:
To ask the Secretary of State for Transport, if her Department will publish changes in bus funding allocations by local transport authority for 2025–26 and 2026–27.
Answered by Simon Lightwood - Parliamentary Under-Secretary (Department for Transport)
On 5 December, the Government confirmed investment of over £3 billion from 2026/27 for the rest of the spending review period to support local leaders and bus operators across the country to improve bus services for millions of passengers. This includes multi-year allocations for local authorities under the Local Authority Bus Grant (LABG) totalling nearly £700 million per year, ending the short-term approach to bus funding and giving councils the certainty they need to plan ahead.
The formula used to calculate LABG allocations in 2025/26 was the Government’s first step towards ending competitive allocations and it considered population size, levels of deprivation and the extent of existing bus services. To prevent sharp decreases of funding, and as part of the Government’s effort to rebalance inequalities created by competitive allocations, losses were capped at 25%.
We revised this formula for 2026/27 onwards to give a greater weighting to levels of deprivation and population, and to cap any losses at 5% in our continued effort to end the inequalities of competitive allocations once and for all. The formula now also includes consideration of the rurality of local areas in response to a recommendation from the Transport Select Committee.
Further details on the funding formula and local authority allocations for 2026/27 onwards have been published on GOV.UK at: https://www.gov.uk/government/publications/local-authority-bus-grant-allocations. LABG allocations for 2025/26 are also published on GOV.UK at: https://www.gov.uk/government/publications/bus-service-improvement-plans-local-transport-authority-allocations/total-combined-bus-funding-allocations-2025-to-2026.
In addition to the LABG, the Government has also introduced a £3 million Bus Franchising Fund for Mayoral Combined Authorities that are pursuing franchising to apply for in 26/27, such as Liverpool City Region, to help support their transition to franchised services.
Asked by: Anneliese Midgley (Labour - Knowsley)
Question to the Department for Transport:
To ask the Secretary of State for Transport, if she will set out the changes to the bus funding allocations formula between 2025-26 and 2026-27.
Answered by Simon Lightwood - Parliamentary Under-Secretary (Department for Transport)
On 5 December, the Government confirmed investment of over £3 billion from 2026/27 for the rest of the spending review period to support local leaders and bus operators across the country to improve bus services for millions of passengers. This includes multi-year allocations for local authorities under the Local Authority Bus Grant (LABG) totalling nearly £700 million per year, ending the short-term approach to bus funding and giving councils the certainty they need to plan ahead.
The formula used to calculate LABG allocations in 2025/26 was the Government’s first step towards ending competitive allocations and it considered population size, levels of deprivation and the extent of existing bus services. To prevent sharp decreases of funding, and as part of the Government’s effort to rebalance inequalities created by competitive allocations, losses were capped at 25%.
We revised this formula for 2026/27 onwards to give a greater weighting to levels of deprivation and population, and to cap any losses at 5% in our continued effort to end the inequalities of competitive allocations once and for all. The formula now also includes consideration of the rurality of local areas in response to a recommendation from the Transport Select Committee.
Further details on the funding formula and local authority allocations for 2026/27 onwards have been published on GOV.UK at: https://www.gov.uk/government/publications/local-authority-bus-grant-allocations. LABG allocations for 2025/26 are also published on GOV.UK at: https://www.gov.uk/government/publications/bus-service-improvement-plans-local-transport-authority-allocations/total-combined-bus-funding-allocations-2025-to-2026.
In addition to the LABG, the Government has also introduced a £3 million Bus Franchising Fund for Mayoral Combined Authorities that are pursuing franchising to apply for in 26/27, such as Liverpool City Region, to help support their transition to franchised services.
Asked by: Anneliese Midgley (Labour - Knowsley)
Question to the Department for Education:
To ask the Secretary of State for Education, what steps her Department is taking to help ensure that councils with above-average demand for children’s social care receive adequate resources under the revised needs-based formula.
Answered by Josh MacAlister - Parliamentary Under-Secretary (Department for Education)
The existing formula, last updated in 2013/14, is significantly outdated and no longer reflects current levels of need. Since then, many local authorities have experienced substantial changes in deprivation, child population density, and other factors that drive demand for services.
The Children and Young People’s Services formula provides a more accurate and robust assessment of each local authority’s relative need for children’s services. It does so by analysing a combination of child and neighbourhood characteristics that best predict whether a child will engage with social care. These include child‑level factors such as age, gender, and eligibility for free school meals, alongside neighbourhood indicators such as deprivation and poor health.
This approach ensures that councils with the greatest levels of relative need receive the largest shares of available funding, enabling them to effectively deliver vital services.
Asked by: Anneliese Midgley (Labour - Knowsley)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, what estimate she has made of the (a) number of Child Trust Fund accounts that remain unclaimed and (b) value of funds held in those unclaimed Child Trust Fund accounts.
Answered by Lucy Rigby - Economic Secretary (HM Treasury)
The number of Child Trust Funds that have matured and have not been claimed or transferred to an ISA, and the value of funds held in these accounts, can be found in the Child Trust Fund tables of the Annual Savings Statistics.
https://www.gov.uk/government/statistics/annual-savings-statistics-2025
Table 1a: Market Value of CTFs as of 5 April 2025 | Number of accounts | Average Market Value (£) | Total Market Value (£ Million) |
Matured This Year (Continuing) | 295 | 2,039 | 602 |
Matured Previously (Continuing) | 463 | 1,942 | 899 |
Asked by: Anneliese Midgley (Labour - Knowsley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the NHS is appropriately prepared for winter flu-related admissions in 2025 and early 2026.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We have started earlier and done more than ever to prepare for winter this year. We continue to monitor the impact of winter pressures on the National Health Service over the winter months, providing additional support to services across the country as needed.
The Department is continuing to take key steps to ensure the health service is prepared throughout the colder months. This includes taking actions to try and reduce demand pressure on accident and emergency departments, increasing vaccination rates, and offering health checks to the most vulnerable, as well as stress-testing integrated care board and trust winter plans to ensure they are able to meet demand and ensure patient flow.
Flu is a recurring pressure that the NHS faces every winter. There is particular risk of severe illness for older people, the very young, pregnant people, and those with certain underlying health conditions. The flu vaccine remains the best form of defense against influenza, particularly for the most vulnerable, and continues to be highly effective at preventing severe disease and hospitalisation. This year we have:
Asked by: Anneliese Midgley (Labour - Knowsley)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what measures are in place to reduce pressure on the NHS from flu-related hospital admissions this winter.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We have started earlier and done more than ever to prepare for winter this year. We continue to monitor the impact of winter pressures on the National Health Service over the winter months, providing additional support to services across the country as needed.
The Department is continuing to take key steps to ensure the health service is prepared throughout the colder months. This includes taking actions to try and reduce demand pressure on accident and emergency departments, increasing vaccination rates, and offering health checks to the most vulnerable, as well as stress-testing integrated care board and trust winter plans to ensure they are able to meet demand and ensure patient flow.
Flu is a recurring pressure that the NHS faces every winter. There is particular risk of severe illness for older people, the very young, pregnant people, and those with certain underlying health conditions. The flu vaccine remains the best form of defense against influenza, particularly for the most vulnerable, and continues to be highly effective at preventing severe disease and hospitalisation. This year we have: